Post Resch Tallon Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-175
Closed -$210K – 143
2026
Q2
$210K Buy
+175
New +$179K 0.15% 119
2026
Q1
– Sell
-204
Closed -$219K – 125
2025
Q4
$219K Buy
+204
New +$195K 0.19% 92

Other funds holding LLY

Post Resch Tallon Group's LLY Position: Q3 2026 in Review

Post Resch Tallon Group sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 175 shares — an estimated $210K sold.

Post Resch Tallon Group first reported a position in LLY in Q4 2025 and held it in 2 quarters. The position peaked at $219K in Q4 2025. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Post Resch Tallon Group reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
  • Post Resch Tallon Group sold 175 Eli Lilly shares in Q3 2026, an estimated $210K.
  • Post Resch Tallon Group first reported a position in Eli Lilly in Q4 2025 and held it in 2 quarters.
  • Post Resch Tallon Group's Eli Lilly position peaked at $219K in Q4 2025.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Post Resch Tallon Group's 13F filing for Q3 2026, filed 9 Oct 2026.